Trials / Completed
CompletedNCT02037893
Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media
A Four-arm, Randomized, Double-blind, Active and Placebo Controlled Study to Determine the Safety and Efficacy of a Combination Antipyrine and Benzocaine Otic Solution Compared With Antipyrine Otic Solution Alone, Benzocaine Otic Solution Alone and to Placebo Otic Solution to Relieve Pain Symptoms in Children With Acute Otitis Media.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Currax Pharmaceuticals · Industry
- Sex
- All
- Age
- 2 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to compare the effect of treatment with a combination of ear solutions on the reduction of pain symptoms at 1 hour after dosing in children with acute otitis media.
Detailed description
Reduction of pain symptoms will be measured by using the Face, Legs, Activity, Cry, Consolability Scale (FLACC) and the Faces pain Scale Revised (FPS-R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antipyrine and Benzocaine otic solution | antipyrine 54 mg and benzocaine 14 mg |
| DRUG | Antipyrine Otic Solution | Antipyrine 54 mg and glycerine dehydrated to 1.0 mL |
| DRUG | Benzocaine Otic Solution | benzocaine 14 mg and glycerine dehydrated to 1.0 mL |
| DRUG | Placebo Otic solution | Placebo otic solution will be glycerin that is dehydrated |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-01-16
- Last updated
- 2024-08-07
- Results posted
- 2018-08-31
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02037893. Inclusion in this directory is not an endorsement.